Inventor · disambiguated record
Tony Giordano
Also filed as: GIORDANO TONY
12 granted patents·5 pending applications·284 citations·filing 1996–2024
92Inventor score
Files withMESSAGE PHARMACEUTICALS5ALNYLAM PHARMACEUTICALS INC2GREIG NIGEL H2BEARSDEN BIO INC1GIORDANO TONY1
Top patents by PatentIndex Score
17 records- 0189US6936432B2Bacterial RNase P proteins and their use in identifying antibacterial compoundsMESSAGE PHARMACEUTICALS·Filed 2001·Granted Aug 30, 2005·37 cites·15 claims
- 0288US7973057B2Thalidomide analogsUS HEALTH·Filed 2004·Granted Jul 5, 2011·30 cites·11 claims
- 0383US6872850B2Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAsMESSAGE PHARMACEUTICALS·Filed 2002·Granted Mar 29, 2005·15 cites·8 claims
- 0483US6448007B1Functional genomic screen for post-transcriptional 5′ and 3′ regulatory elementsMESSAGE PHARMACEUTICALS·Filed 2000·Granted Sep 10, 2002·17 cites·33 claims
- 0575US7001924B2Inhibitors of RNase P proteins as antibacterial compoundsMESSAGE PHARMACEUTICALS·Filed 2002·Granted Feb 21, 2006·11 cites·27 claims
- 0674US8546430B2Thalidomide analogsGREIG NIGEL H·Filed 2011·Granted Oct 1, 2013·2 cites·19 claims
- 0774US6107029AUniversal method for detecting interactions between RNA molecules and RNA binding proteinsMESSAGE PHARMACETICALS INC·Filed 1996·Granted Aug 22, 2000·57 cites·34 claims
- 0874US5859227ARNA sequences which interact with RNA-binding proteinsBEARSDEN BIO INC·Filed 1997·Granted Jan 12, 1999·54 cites·7 claims
- 0971US6004749AMethod for identifying compounds affecting RNA/RNA binding protein interactionsMESSAGE PHARMACEUTICALS·Filed 1997·Granted Dec 21, 1999·42 cites·22 claims
- 1068US2025082624A1Methods of treating cognitive impairmentNEUROTHERAPIA INC·Filed 2024·Application pending·0 cites
- 1159US8853253B2Thalidomide analogsGREIG NIGEL H·Filed 2012·Granted Oct 7, 2014·0 cites·15 claims
- 1258US2015232930A1Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cellALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1358US2016083723A1Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cellALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1452US6465176B1Method for identifying compounds RNA/RNA binding protein interactionsMESSAGE PHARMACEUTICALS INC·Filed 1998·Granted Oct 15, 2002·19 cites·13 claims
- 1551US2014309436A1Thalidomide analogsP2D INC·Filed 2014·Application pending·0 cites
- 1647US2002132257A1Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cellFiled 2002·Application pending·0 cites
- 1745US9051566B2Post-transcriptional gene silencing using expressed double stranded RNAGIORDANO TONY·Filed 2004·Granted Jun 9, 2015·0 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →